A- A A+

Identification of the socio-cultural barriers of drug addiction treatment in Iran. 

Razaghi E, Farhoudian A, Pilevari A, Noroozi A, Hooshyari Z, Radfar R, Malekinejad M. 

Heliyon. 2023 Apr 18;9(5):e15566. doi: 10.1016/j.heliyon.2023.e15566. PMID: 37131427; PMCID: PMC10149210.


Development and Psychometric Evaluation of the IPV Internalized Stigma Scale. 

Brunton R, Harris KM. 

J Interpers Violence. 2023 Apr 19:8862605231162653. doi: 10.1177/08862605231162653. Epub ahead of print. PMID: 37073944.


Exploratory Factor Analysis of a French Adapted Version of the Substance Abuse Attitude Survey among Medical Students in Belgium. 

Richelle L, Dramaix-Wilmet M, Kacenelenbogen N, Kornreich C. 

Int J Environ Res Public Health. 2023 Mar 31;20(7):5356. doi: 10.3390/ijerph20075356. PMID: 37047970; PMCID: PMC10094367.


Original Research: Nurses' Self-Assessed Knowledge, Attitudes, and Educational Needs Regarding Patients with Substance Use Disorder. 

Kratovil, Amanda PhD, RN; Schuler, Monika S. PhD, FNP-BC, CNE; Vottero, Beth A. PhD, RN, CNE; Aryal, Gokarna PhD. 

AJN, American Journal of Nursing 123(4):p 26-33, April 2023. | DOI: 10.1097/01.NAJ.0000925496.18847.c6


A National Portrait of Public Attitudes toward Opioid Use in the US: A Latent Class Analysis. 

Walters SM, Liu W, Lamuda P, Huh J, Brewer R, Johnson O, Bluthenthal RN, Taylor B, Schneider JA. 

Int J Environ Res Public Health. 2023 Mar 2;20(5):4455. doi: 10.3390/ijerph20054455. PMID: 36901465; PMCID: PMC10001548.


Curbing Physician Stigma Toward Adolescents With Nicotine and Opiate Use. 

Appel G, Shin B, Shah A, Avery JD. 

Prim Care Companion CNS Disord. 2023 Mar 14;25(2):22br03358. doi: 10.4088/PCC.22br03358. PMID: 36946564.


Experiences of healthcare and substance use treatment provider-based stigma among patients receiving methadone. 

Carl A, Pasman E, Broman MJ, Lister JJ, Agius E, Resko SM. 

Drug Alcohol Depend Rep. 2023 Feb 7;6:100138. doi: 10.1016/j.dadr.2023.100138. PMID: 36994374; PMCID: PMC10040326.


Werden drogenkonsumierende Menschen stigmatisiert – insbesondere vom Fachpersonal? 

Menschen mit Abhängigkeitserkrankungen sind zahlreichen Vorurteilen ausgesetzt. In einer Studie wurden Fachpersonen von Akutspitälern und Behörden sowie Patient:innen eines Ambulatoriums der Universitären Psychiatrischen Kliniken Basel befragt, wie Menschen mit einer Abhängigkeitserkrankung Stigmatisierung im Kontakt mit sozialen Institutionen, Krankenhäusern und Behörden wahrnehmen. Über 70 % der befragten Patient:innen fühlen sich aufgrund ihrer Abhängigkeitserkrankung stigmatisiert. Je mehr Betroffene Stigmatisierungen durch ihr psychosoziales Hilfesystem erfahren, desto weniger nehmen sie Unterstützungsangebote an. (STEPHANIE BUSCHNER-FEHR, THOMAS MÜLLER, OTTO SCHMID in: Suchtmagazin, Schweiz, 2023-1, Jg. 49, S. 11 – 15)


Crisis Intervention Team (CIT) training and impact on mental illness and substance use-related stigma among law enforcement. 

Nick GA, Williams S, Lekas HM, Pahl K, Blau C, Kamin D, Fuller-Lewis C. 

Drug Alcohol Depend Rep. 2022 Sep 29;5:100099. doi: 10.1016/j.dadr.2022.100099. PMID: 36844168; PMCID: PMC9949319.


Examining stigma relating to substance use and contextual factors in social media discussions. 

Chen AT, Johnny S, Conway M. 

Drug Alcohol Depend Rep. 2022 May 5;3:100061. doi: 10.1016/j.dadr.2022.100061. PMID: 36845987; PMCID: PMC9948814.


Barriers to and facilitators of hormonal and long-acting reversible contraception access and use in the US among reproductive-aged women who use opioids: A scoping review. 

Charron E, Kent-Marvick J, Gibson T, Taylor E, Bouwman K, Sani GM, Simonsen SE, Stone RH, Kaiser JE, McFarland MM. 

Prev Med Rep. 2023 Jan 18;32:102111. doi: 10.1016/j.pmedr.2023.102111. PMID: 36747991; PMCID: PMC9898069.


A randomized controlled trial of an intervention to reduce stigma toward people with opioid use disorder among primary care clinicians. 

Hooker SA, Crain AL, LaFrance AB, Kane S, Fokuo JK, Bart G, Rossom RC.

Addict Sci Clin Pract. 2023 Feb 11;18(1):10. doi: 10.1186/s13722-023-00366-1. PMID: 36774521; PMCID: PMC9922036.


Impact of Stigma on Clinician Training for Opioid Use Disorder Care: A Qualitative Study in a Primary Care Learning Collaborative. 

Klusaritz H, Bilger A, Paterson E, Summers C, Barg FK, Cronholm PF, Saine ME, Sochalski J, Doubeni CA. 

Ann Fam Med. 2023 Feb;21(Suppl 2):S31-S38. doi: 10.1370/afm.2920. PMID: 36849482; PMCID: PMC9970664.


Australien. Experiences of stigma while visiting healthcare services among people who use drugs in Australia, 2022

The Ecstasy and Related Drugs Reporting System (EDRS) and the Illicit Drug Reporting System (IDRS) are national drug monitoring systems intended to identify emerging trends of local and national concern in illicit drug markets, and form part of Drug Trends.

This bulletin investigates the experience of stigma while visiting healthcare services among people who regularly inject drugs and people who regularly use ecstasy and/or other stimulants. (UNSW MEDICINE - National Drug and Alcohol Research Centre, Australien, 27.02.2023)


Kanada. Decriminalizing hard drugs in B.C. will help reduce the stigma of substance abuse

Substance use disorder is a chronic but treatable medical condition. 

Unlike other physical and mental health conditions, however, substance use disorder — or addiction — has historically been seen as a moral failing and was for many years relegated to the fringes of the medical community. 

Instead of receiving treatment in an accessible medical setting, many individuals went untreated or turned to a largely unregulated system of public and private treatment options. Drug use was criminalized and because many still believe that people who use drugs are engaging in deliberately deviant behaviour, we often choose to punish, rather than treat, drug addiction.

That’s why British Columbia’s recent move to eliminate criminal penalties for the possession of small amounts of illicit drugs for personal use is an important step toward the decriminalization of addiction. (The Conversation, Frankreich, 20.02.2023)


Reducing stigma toward mental illness and substance use issues in primary health care in Chile: Protocol of a cluster controlled trial study. 

Sapag JC, Traub C, Velasco PR, Arratia T, Alvarado R, Aracena M, Poblete FC, Villarroel L, Bravo P, Álvarez-Huenchulaf C, Jofré Escalona A, Vargas-Malebrán N, Bobbili S, Bustamante I, Khenti A, Corrigan PW. 

Front Psychiatry. 2022 Dec 20;13:1083042. doi: 10.3389/fpsyt.2022.1083042. PMID: 36606131; PMCID: PMC9808783.


'We don't live in a harm reduction world, we live in a prohibition world': tensions arising in the design of drug alerts. 

Volpe I, Brien R, Grigg J, Tzanetis S, Crawford S, Lyons T, Lee N, McKinnon G, Hughes C, Eade A, Barratt MJ. 

Harm Reduct J. 2023 Jan 9;20(1):3. doi: 10.1186/s12954-022-00716-3. PMID: 36624508; PMCID: PMC9829230.


Belief that addiction is a discrete category is a stronger correlate with stigma than the belief that addiction is biologically based. 

Siddiqui H, Rutherford MD. 

Subst Abuse Treat Prev Policy. 2023 Jan 10;18(1):3. doi: 10.1186/s13011-022-00512-z. PMID: 36627629; PMCID: PMC9830773.


Internalized stigma in mental health staff with lived experience of mental crises-Does the professional role protect against self-stigmatization? 

Stuetzle S, Brieger A, Lust C, Ponew A, Speerforck S, von Peter S. 

Front Psychiatry. 2023 Jan 12;13:1078478. doi: 10.3389/fpsyt.2022.1078478. PMID: 36713908; PMCID: PMC9877507.


The stigmatization of mental illness by mental health professionals: Scoping review and bibliometric analysis. 

Jauch M, Occhipinti S, O’Donovan A (2023) 

PLoS ONE 18(1): e0280739. doi.org/10.1371/journal.pone.0280739


Attitudes towards people who use substances: a survey of mental health clinicians from an urban hospital in British Columbia. 

Russolillo A, Guan M, Dogherty EJ, Kolar M, Du J, Brynjarsdóttir E, Carter M. 

Harm Reduct J. 2023 Jan 19;20(1):7. doi: 10.1186/s12954-023-00733-w. PMID: 36658585; PMCID: PMC9850574.


Should I Stay or Should I Go? A Qualitative Exploration of Stigma and Other Factors Influencing Opioid Agonist Treatment Journeys. 

Carlisle VR, Maynard OM, Bagnall D, Hickman M, Shorrock J, Thomas K, Kesten J. 

International Journal of Environmental Research and Public Health. 2023; 20(2):1526. doi.org/10.3390/ijerph20021526


USA. Hospitals look to storytelling to reduce stigma toward people with addiction 

(…) Most health care professionals hold negative attitudes toward patients with substance use disorders, according to a 2013 systematic review of more than two dozen studies. These attitudes can result in patients receiving suboptimal care. (…)

Throughout society, stigma continues to surround people living with addiction. Experts say in order to combat the opioid crisis, there needs to be greater societal understanding about addiction and more empathy toward people with substance use disorders. 

One strategy, spearheaded by researchers in the Midwest, involves using personal narratives to address stigma and biases held by medical professionals. (WBAA, USA, 05.01.2023)


Addressing Stigma is Not Enough. 

Amon JJ, Sun N, Iovita A, Jurgens R, Csete J. 

Health Hum Rights. 2022 Dec;24(2):111-114. PMID: 36579301; PMCID: PMC9790942.


Temporal associations between depressive features and self-stigma in people with substance use disorders related to heroin, amphetamine, and alcohol use: a cross-lagged analysis. 

Saffari M, Chang KC, Chen JS, Chang CW, Chen IH, Huang SW, Liu CH, Lin CY, Potenza MN. 

BMC Psychiatry. 2022 Dec 21;22(1):815. doi: 10.1186/s12888-022-04468-z. PMID: 36544132; PMCID: PMC9768939.


Stigma experienced by people living with HIV who are on methadone maintenance treatment and have symptoms of common mental disorders in Hanoi, Vietnam: a qualitative study. 

Tran HV, Filipowicz TR, Landrum KR, Nong HTT, Tran TTT, Pence BW, Go VF, Le GM, Nguyen MX, Verhey R, Chibanda D, Ho HT, Gaynes BN. 

AIDS Res Ther. 2022 Dec 14;19(1):63. doi: 10.1186/s12981-022-00491-y. PMID: 36517849; PMCID: PMC9753276.


Comparisons of psychological distress and self-stigma among three types of substance use disorders receiving treatment-as-usual approaches: real-world data from a 9-month longitudinal study.

Chang KC, Chen HP, Huang SW, Chen JS, Potenza MN, Pakpour AH, Lin CY. 

Ther Adv Chronic Dis. 2022 Dec 2;13:20406223221140393. doi: 10.1177/20406223221140393. PMID: 36483780; PMCID: PMC9723802.


The "goldfish bowl": a qualitative study of the effects of heightened surveillance on people who use drugs in a rural and coastal Canadian setting. 

Bardwell G, Mansoor M, Van Zwietering A, Cleveland E, Snell D, Kerr T. 

Harm Reduct J. 2022 Dec 7;19(1):136. doi: 10.1186/s12954-022-00725-2. PMID: 36476225; PMCID: PMC9730691.


Time to Stop Using the Word “Smoker”: Reflecting on the Role of Language in Advancing the Field of Nicotine and Tobacco Research,

Renee D Goodwin, PhD, MPH, Lisa K Walker, PhD, 

Nicotine & Tobacco Research, 2022;, ntac218,  doi.org/10.1093/ntr/ntac218


UK. Stigma Kills - See the person. Hear their story.

Everyone knows someone who experiences addiction.

We all know someone who has experienced addiction at some point in their lives, from substance misuse to gambling or gaming addiction.

Although addiction is a common health issue that requires medical intervention and support, people suffering from this illness are some of the most stigmatised in society, often seen as not even unwell and in some way deserving of their experiences. (NHS – National Health Service, Addictions Provider Alliance, UK, November 2022)